Search Results - "Bettcher, B. M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Longitudinal Inflammation, Cognitive Decline, and Alzheimer's Disease: A Mini-Review by Bettcher, B M, Kramer, J H

    Published in Clinical pharmacology and therapeutics (01-10-2014)
    “…The role of inflammation in cognitive decline has generated considerable interest, although few longitudinal evaluations have been conducted. A review of the…”
    Get full text
    Journal Article
  2. 2

    Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease by Lalli, M A, Bettcher, B M, Arcila, M L, Garcia, G, Guzman, C, Madrigal, L, Ramirez, L, Acosta-Uribe, J, Baena, A, Wojta, K J, Coppola, G, Fitch, R, de Both, M D, Huentelman, M J, Reiman, E M, Brunkow, M E, Glusman, G, Roach, J C, Kao, A W, Lopera, F, Kosik, K S

    Published in Molecular psychiatry (01-11-2015)
    “…We have sequenced the complete genomes of 72 individuals affected with early-onset familial Alzheimer's disease caused by an autosomal dominant, highly…”
    Get full text
    Journal Article
  3. 3

    More than memory impairment in voltage-gated potassium channel complex encephalopathy by Bettcher, B. M., Gelfand, J. M., Irani, S. R., Neuhaus, J., Forner, S., Hess, C. P., Geschwind, M. D.

    Published in European journal of neurology (01-10-2014)
    “…Background and purpose Autoimmune encephalopathies (AEs) are a heterogeneous group of neurological disorders that affect cognition. Although memory…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers by Casaletto, Kaitlin B, Elahi, Fanny M, Bettcher, Brianne M, Neuhaus, John, Bendlin, Barbara B, Asthana, Sanjay, Johnson, Sterling C, Yaffe, Kristine, Carlsson, Cynthia, Blennow, Kaj, Zetterberg, Henrik, Kramer, Joel H

    Published in Neurology (24-10-2017)
    “…OBJECTIVE:To determine the association between synaptic functioning as measured via neurogranin in CSF and cognition relative to established Alzheimer disease…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence? by Casaletto, K.B., Elahi, F.M., Fitch, R., Walters, S., Fox, E., Staffaroni, A.M., Bettcher, B.M., Zetterberg, H., Karydas, A., Rojas, J.C., Boxer, A.L., Kramer, J.H.

    Published in Cytokine (Philadelphia, Pa.) (01-11-2018)
    “…•MSD HPE and Quanterix Simoa are analytic platforms to detect biofluid cytokines.•Detectability and reliability of the same cytokines did not differ across…”
    Get full text
    Journal Article
  8. 8

    Characterization of everyday functioning in mild cognitive impairment: a direct assessment approach by Giovannetti, Tania, Bettcher, Brianne Magouirk, Brennan, Laura, Libon, David J, Burke, Marykate, Duey, Katia, Nieves, Christine, Wambach, Denene

    Published in Dementia and geriatric cognitive disorders (01-01-2008)
    “…To evaluate the degree and pattern of functional difficulties in mild cognitive impairment (MCI) via direct observation of everyday task performance. MCI (n =…”
    Get more information
    Journal Article
  9. 9

    Exosomal biomarkers in Down syndrome and Alzheimer's disease by Hamlett, Eric D., Ledreux, Aurélie, Potter, Huntington, Chial, Heidi J., Patterson, David, Espinosa, Joaquin M., Bettcher, Brianne M., Granholm, Ann-Charlotte

    Published in Free radical biology & medicine (01-01-2018)
    “…Every person with Down syndrome (DS) has the characteristic features of Alzheimer's disease (AD) neuropathology in their brain by the age of forty, and most go…”
    Get full text
    Journal Article